Will Lamb Weston's International segment Adjusted EBITDA margin print below 8% in Q4 FY26 (reported July 2026)?

International segment EBITDA margin has been running near 4% per the Atomic Auditor read, and crossing to 8%+ in a single quarter requires ~400 bps of expansion. Q4 seasonal uplift (150-300 bps typically) plus Argentina plant closure removing a drag is not sufficient on its own to bridge. The mid-teens European crop cost decline is explicitly a FY27 tailwind — it flows through COGS next year, not Q4 FY26. Management messaging has been optimistic but not specifically guiding to 8%+ margin. The single material upside risk is a cost-savings pull-forward or restructuring-charge reclassification that lifts the adjusted line above trend. Settle at 0.78 — margin remains below 8% is the modal outcome.

The bear case for NO (margin crosses 8%) rests on three compounding lifts: Q4 seasonality (strong Northern Hemisphere food-service demand), Argentina plant closure removing a fixed-cost drag, and cost savings pull-forward. Each is real and could sum to 300-500 bps. The $33M Q3 write-off was one-time so its non-recurrence alone lifts reported margin. However, the mid-teens crop cost is firmly FY27, and International demand recovery is 2+ years per Atomic Auditor. Net probability of YES (margin still below 8%) slightly lower than consensus at 0.74 reflecting the multiple compounding adjustment items.

Reporting mechanics matter: the International segment is measured on adjusted EBITDA, and management has already excluded the Q3 write-off. If we start from an already-adjusted baseline near 4-5%, even generous seasonality and operational lifts leave margin in the 6-7% range for Q4. Consolidation Calibrator's framing — International is the divestiture candidate — implies management may not be investing aggressively in short-term margin defense. Further, the inventory-driven working-capital benefit flagged by Stress Scanner does not translate to P&L margin. Settle at 0.80.

Balanced read: International margin at ~4% baseline per Atomic Auditor, plus 150-300 bps Q4 seasonality plus 50-100 bps Argentina closure benefit gets to ~6-8% range. The 8% threshold is right at the upper bound of plausible Q4 outcomes without the crop-cost tailwind. Given broken unit economics and 2+ year European recovery timeline, YES (below 8%) is modal. 0.75 reflects moderate confidence.

Slightly lower probability because: (1) Q4 is LW's seasonally strongest period; (2) new Exec Chair Craps has been messaging International turnaround, suggesting management will manage margin disclosure toward visible stabilization; (3) Argentina exit + mix improvement could sum larger than model expects; (4) the Q3 write-off non-recurrence alone is a meaningful lift given the $33M magnitude against a ~$900M annual International revenue base. 0.72 reflects these offsets against structural weakness.

Revenue base dynamics: ~$900M annual International segment, Q4 likely ~$230M. At 4% margin = $9M EBITDA. 8% requires $18M EBITDA — a $9M step-change. Crop savings not in play, Argentina benefit maybe $3-5M quarterly, seasonality $5-8M, write-off non-recurrence $5-10M (amortized comparison). Plausibly reaches 7-9% in point-estimate. The 8% cliff is close. Settle at 0.77 reflecting the thin margin to the threshold.

International at ~4% baseline needs 400 bps expansion for 8%. Q4 seasonality helps but not enough alone. Crop cost tailwind is FY27. Most likely outcome is 5-8% margin print with material uncertainty about exactly where in that band. YES (below 8%) is slightly favored. 0.76.

Moderate read favoring YES but lower probability: Argentina closure + Q3 write-off non-recurrence + seasonality could combine to lift margin near the threshold. Management disclosure choices matter. 0.72.

International segment trough continues. 8% threshold is a meaningful hurdle given 4% starting point. Crop tailwind is next year. Anchor on 0.78 probability of margin staying below 8%.